Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001193125-25-249298
Filing Date
2025-10-24
Accepted
2025-10-24 06:16:29
Documents
5
Period of Report
2025-10-24

Document Format Files

Seq Description Document Type Size
1 6-K/A business_update_-_10-21-.htm 6-K/A 36589
2 EX-1.1 imab-ex1_1.htm EX-1.1 1080134
3 EX-1.2 imab-ex1_2.htm EX-1.2 90381
4 EX-1.3 imab-ex1_3.htm EX-1.3 708411
5 EX-1.4 imab-ex1_4.htm EX-1.4 667691
  Complete submission text file 0001193125-25-249298.txt   2584229
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-39173 | Film No.: 251414220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)